{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:26:21Z","timestamp":1715646381919},"reference-count":96,"publisher":"Japanese Association of Virology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Uirusu"],"published-print":{"date-parts":[[2022]]},"DOI":"10.2222\/jsv.72.7","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T22:18:19Z","timestamp":1698358699000},"page":"7-18","source":"Crossref","is-referenced-by-count":0,"title":["South American Hemorrhagic Fever viruses and the cutting edge of the vaccine and antiviral development","\u5357\u7c73\u51fa\u8840\u71b1\u30a6\u30a4\u30eb\u30b9\u3068\u305d\u306e\u611f\u67d3\u4e88\u9632\u30fb\u6cbb\u7642\u6cd5\u306e\u6700\u524d\u7dda"],"prefix":"10.2222","volume":"72","author":[{"given":"Meion","family":"LEE","sequence":"first","affiliation":[{"name":"National Research Center for the Control and Prevention of Infectious Diseases (CCPID), Nagasaki University"},{"name":"Department of Cell Regulation, Graduate School of Biomedical Sciences, Nagasaki University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"KOMA","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Graduate School of Medicine, Tokushima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"IWASAKI","sequence":"additional","affiliation":[{"name":"Laboratory of Emerging Viral Diseases, International Research Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzo","family":"URATA","sequence":"additional","affiliation":[{"name":"National Research Center for the Control and Prevention of Infectious Diseases (CCPID), Nagasaki University"},{"name":"Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1062","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1\uff09\tRadoshitzky, S. R. et al. Past, present, and future of arenavirus taxonomy. Arch Virol, doi:10.1007\/s00705-015-2418-y (2015).","DOI":"10.1007\/s00705-015-2418-y"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2\uff09\tHepojoki, J. et al. Characterization of Haartman Institute snake virus-1 (HISV-1) and HISV-like viruses-The representatives of genus Hartmanivirus, family Arenaviridae. PLoS Pathog 14, e1007415, doi:10.1371\/journal.ppat.1007415 (2018).","DOI":"10.1371\/journal.ppat.1007415"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3\uff09\tShi, M. et al. The evolutionary history of vertebrate RNA viruses. Nature 556, 197-202, doi:10.1038\/s41586-018-0012-7 (2018).","DOI":"10.1038\/s41586-018-0012-7"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4\uff09\tTani, H. & Urata, S. [Arenavirus research and antiviral candidate]. Uirusu 68, 51-62, doi:10.2222\/jsv.68.51 (2018).","DOI":"10.2222\/jsv.68.51"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5\uff09\tTani, H., Fukushi, S., Yoshikawa, T., Saijo, M. & Morikawa, S. [Arenavirus infections]. Uirusu 62, 229-238, doi:10.2222\/jsv.62.229 (2012).","DOI":"10.2222\/jsv.62.229"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6\uff09\tUrata, S. Molecular mechanisms of highly pathogenic viruses' replication and theri applications for a novel drug discovery. Uirusu 70, 69-82 (2020).","DOI":"10.2222\/jsv.70.69"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7\uff09\tArmstrong C., L. R. Experimental lymphocytic choriomeningitis of monkeys and mice produced by a virus encountered in studies of the 1933 St. Lous encephalitis epidemic. Public Health Report 49, 1019-1027 (1934).","DOI":"10.2307\/4581290"},{"key":"8","unstructured":"8\uff09\tParodi, A. S. et al. [Concerning the epidemic outbreak in Junin]. Dia Med 30, 2300-2301 (1958)."},{"key":"9","doi-asserted-by":"publisher","unstructured":"9\uff09\tJohnson, K. M. et al. Virus Isolations from Human Cases of Hemorrhagic Fever in Bolivia. Proc Soc Exp Biol Med 118, 113-118, doi:10.3181\/00379727-118-29772 (1965).","DOI":"10.3181\/00379727-118-29772"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10\uff09\tFrame, J. D., Baldwin, J. M., Jr., Gocke, D. J. & Troup, J. M. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg 19, 670-676 (1970).","DOI":"10.4269\/ajtmh.1970.19.670"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11\uff09\tSalas, R. et al. Venezuelan haemorrhagic fever. Lancet 338, 1033-1036, doi:10.1016\/0140-6736(91)91899-6 (1991).","DOI":"10.1016\/0140-6736(91)91899-6"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12\uff09\tTesh, R. B., Jahrling, P. B., Salas, R. & Shope, R. E. Description of Guanarito virus (Arenaviridae: Arenavirus), the etiologic agent of Venezuelan hemorrhagic fever. Am J Trop Med Hyg 50, 452-459, doi:10.4269\/ajtmh.1994.50.452 (1994).","DOI":"10.4269\/ajtmh.1994.50.452"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13\uff09\tLisieux, T. et al. New arenavirus isolated in Brazil. Lancet 343, 391-392, doi:10.1016\/s0140-6736(94)91226-2 (1994).","DOI":"10.1016\/S0140-6736(94)91226-2"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14\uff09\tDelgado, S. et al. Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog 4, e1000047, doi:10.1371\/journal.ppat.1000047 (2008).","DOI":"10.1371\/journal.ppat.1000047"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15\uff09\tDowns, W. G., Anderson, C. R., Spence, L., Aitken, T. H. & Greenhall, A. H. Tacaribe virus, a new agent isolated from Artibeus bats and mosquitoes in Trinidad, West Indies. Am J Trop Med Hyg 12, 640-646 (1963).","DOI":"10.4269\/ajtmh.1963.12.640"},{"key":"16","unstructured":"16\uff09\tBuchmeier, M. J., de la Torre, J.C., Peters, C.J. Arenaviridae. Fields Virology 2, 1283-1303 (2013)."},{"key":"17","unstructured":"17\uff09\tRadoshitzky, S. R., Buchmeier, M.J., de la Torre, J.C. Arenaviridae: The VIruses and THeir Replication. Fields Virology 1, 784-809 (2020)."},{"key":"18","doi-asserted-by":"publisher","unstructured":"18\uff09\tJohnson, K. M., Kuns, M. L., Mackenzie, R. B., Webb, P. A. & Yunker, C. E. Isolation of Machupo virus from wild rodent Calomys callosus. Am J Trop Med Hyg 15, 103-106, doi:10.4269\/ajtmh.1966.15.103 (1966).","DOI":"10.4269\/ajtmh.1966.15.103"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19\uff09\tAguilar, P. V. et al. Reemergence of Bolivian hemorrhagic fever, 2007-2008. Emerg Infect Dis 15, 1526-1528, doi:10.3201\/eid1509.090017 (2009).","DOI":"10.3201\/eid1509.090017"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20\uff09\tEllwanger, J. H. & Chies, J. A. Keeping track of hidden dangers - The short history of the Sabia virus. Rev Soc Bras Med Trop 50, 3-8, doi:10.1590\/0037-8682- 0330-2016 (2017).","DOI":"10.1590\/0037-8682-0330-2016"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21\uff09\tde Mello Malta, F. et al. Sabia Virus-Like Mammarenavirus in Patient with Fatal Hemorrhagic Fever, Brazil, 2020. Emerg Infect Dis 26, 1332-1334, doi:10. 3201\/eid2606.200099 (2020).","DOI":"10.3201\/eid2606.200099"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22\uff09\tEscalera-Antezana, J. P. et al. Clinical features of fatal cases of Chapare virus hemorrhagic fever originating from rural La Paz, Bolivia, 2019: A cluster analysis. Travel Med Infect Dis 36, 101589, doi:10.1016\/ j.tmaid.2020.101589 (2020).","DOI":"10.1016\/j.tmaid.2020.101589"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23\uff09\tCogswell-Hawkinson, A. et al. Tacaribe virus causes fatal infection of an ostensible reservoir host, the Jamaican fruit bat. J Virol 86, 5791-5799, doi:10.1128\/JVI.00201-12 (2012).","DOI":"10.1128\/JVI.00201-12"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24\uff09\tSayler, K. A. et al. Isolation of Tacaribe virus, a Caribbean arenavirus, from host-seeking Amblyomma americanum ticks in Florida. PLoS One 9, e115769, doi:10.1371\/journal.pone.0115769 (2014).","DOI":"10.1371\/journal.pone.0115769"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25\uff09\tRadoshitzky, S. R. et al. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446, 92-96, doi:nature05539 [pii] 10.1038\/nature05539 (2007).","DOI":"10.1038\/nature05539"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26\uff09\tRojek, J. M., Sanchez, A. B., Nguyen, N. T., de la Torre, J. C. & Kunz, S. Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses. J Virol 82, 7677-7687, doi:10.1128\/ JVI.00560-08 (2008).","DOI":"10.1128\/JVI.00560-08"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27\uff09\tMoraz, M. L. et al. Cell entry of Lassa virus induces tyrosine phosphorylation of dystroglycan. Cell Microbiol 15, 689-700, doi:10.1111\/cmi.12078 (2013).","DOI":"10.1111\/cmi.12078"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28\uff09\tSarute, N. et al. TRIM2, a novel member of the antiviral family, limits New World arenavirus entry. PLoS Biol 17, e3000137, doi:10.1371\/journal.pbio.3000137 (2019).","DOI":"10.1371\/journal.pbio.3000137"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29\uff09\tSarute, N. et al. Signal-regulatory protein alpha is an anti-viral entry factor targeting viruses using endocytic pathways. PLoS Pathog 17, e1009662, doi:10.1371\/ journal.ppat.1009662 (2021).","DOI":"10.1371\/journal.ppat.1009662"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30\uff09\tBaird, N. L., York, J. & Nunberg, J. H. Arenavirus infection induces discrete cytosolic structures for RNA replication. J Virol 86, 11301-11310, doi:10.1128\/JVI.01635-12 (2012).","DOI":"10.1128\/JVI.01635-12"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31\uff09\tLinero, F., Welnowska, E., Carrasco, L. & Scolaro, L. Participation of eIF4F complex in Junin virus infection: blockage of eIF4E does not impair virus replication. Cell Microbiol 15, 1766-1782, doi:10.1111\/cmi. 12149 (2013).","DOI":"10.1111\/cmi.12149"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32\uff09\tVolpon, L., Osborne, M. J., Capul, A. A., de la Torre, J. C. & Borden, K. L. Structural characterization of the Z RING-eIF4E complex reveals a distinct mode of control for eIF4E. Proc Natl Acad Sci U S A 107, 5441-5446, doi:0909877107 [pii] 10.1073\/pnas. 0909877107 (2010).","DOI":"10.1073\/pnas"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33\uff09\tKentsis, A. et al. The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E. J Mol Biol 312, 609-623, doi:10.1006\/jmbi.2001.5003 S0022-2836 (01)95003-X [pii] (2001).","DOI":"10.1006\/jmbi.2001.5003"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34\uff09\tUrata, S. & Yasuda, J. Molecular mechanism of arenavirus assembly and budding. Viruses 4, 2049-2079, doi:10.3390\/v4102049 v4102049 [pii] (2012).","DOI":"10.3390\/v4102049"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35\uff09\tRoldan, J. S., Candurra, N. A., Colombo, M. I. & Delgui, L. R. Junin Virus Promotes Autophagy To Facilitate the Virus Life Cycle. J Virol 93, doi:10.1128\/JVI.02307-18 (2019).","DOI":"10.1128\/JVI.02307-18"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36\uff09\tPerez Vidakovics, M. L. A., Ure, A. E., Arrias, P. N., Romanowski, V. & Gomez, R. M. Junin virus induces autophagy in human A549 cells. PLoS One 14, e0218730, doi:10.1371\/journal.pone.0218730 (2019).","DOI":"10.1371\/journal.pone.0218730"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37\uff09\tUrata, S., Noda, T., Kawaoka, Y., Yokosawa, H. & Yasuda, J. Cellular factors required for Lassa virus budding. J Virol 80, 4191-4195, doi:80\/8\/4191 [pii] 10.1128\/ JVI.80.8.4191-4195.2006 (2006).","DOI":"10.1128\/JVI.80.8.4191-4195.2006"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38\uff09\tUrata, S., Yasuda, J. & de la Torre, J. C. The z protein of the new world arenavirus tacaribe virus has bona fide budding activity that does not depend on known late domain motifs. J Virol 83, 12651-12655, doi:JVI.01012-09 [pii] 10.1128\/JVI.01012-09 (2009).","DOI":"10.1128\/JVI.01012-09"},{"key":"39","doi-asserted-by":"publisher","unstructured":"39\uff09\tUrata, S. et al. Analysis of Assembly and Budding of Lujo Virus. J Virol 90, 3257-3261, doi:10.1128\/JVI.03198-15 (2016).","DOI":"10.1128\/JVI.03198-15"},{"key":"40","doi-asserted-by":"publisher","unstructured":"40\uff09\tUrata, S. & de la Torre, J. C. Arenavirus budding. Adv Virol 2011, 180326, doi:10.1155\/2011\/180326 (2011).","DOI":"10.1155\/2011\/180326"},{"key":"41","doi-asserted-by":"publisher","unstructured":"41\uff09\tNunberg, J. H. & York, J. The curious case of arenavirus entry, and its inhibition. Viruses 4, 83-101, doi: 10.3390\/v4010083 viruses-04-00083 [pii] (2012).","DOI":"10.3390\/v4010083"},{"key":"42","doi-asserted-by":"publisher","unstructured":"42\uff09\tKatz, M. et al. Structure and receptor recognition by the Lassa virus spike complex. Nature 603, 174-179, doi:10.1038\/s41586-022-04429-2 (2022).","DOI":"10.1038\/s41586-022-04429-2"},{"key":"43","doi-asserted-by":"publisher","unstructured":"43\uff09\tFan, L., Briese, T. & Lipkin, W. I. Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction. J Virol 84, 1785-1791, doi:JVI.01362-09 [pii] 10.1128\/JVI.01362-09 (2010).","DOI":"10.1128\/JVI.01362-09"},{"key":"44","doi-asserted-by":"publisher","unstructured":"44\uff09\tHuang, C. et al. Highly Pathogenic New World and Old World Human Arenaviruses Induce Distinct Interferon Responses in Human Cells. J Virol 89, 7079-7088, doi:10.1128\/JVI.00526-15 (2015).","DOI":"10.1128\/JVI.00526-15"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45\uff09\tLevis, S. C. et al. Endogenous interferon in Argentine hemorrhagic fever. J Infect Dis 149, 428-433, doi:10.1093\/ infdis\/149.3.428 (1984).","DOI":"10.1093\/infdis\/149.3.428"},{"key":"46","doi-asserted-by":"publisher","unstructured":"46\uff09\tKoma, T., Huang, C., Kolokoltsova, O. A., Brasier, A. R. & Paessler, S. Innate immune response to arenaviral infection: a focus on the highly pathogenic New World hemorrhagic arenaviruses. J Mol Biol 425, 4893-4903, doi:10.1016\/j.jmb.2013.09.028 (2013).","DOI":"10.1016\/j.jmb.2013.09.028"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47\uff09\tHuang, C. et al. Junin virus infection activates the type I interferon pathway in a RIG-I-dependent manner. PLoS Negl Trop Dis 6, e1659, doi:10.1371\/journal.pntd.0001659 (2012).","DOI":"10.1371\/journal.pntd.0001659"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48\uff09\tCuevas, C. D., Lavanya, M., Wang, E. & Ross, S. R. Junin virus infects mouse cells and induces innate immune responses. J Virol 85, 11058-11068, doi:10.1128\/ JVI.05304-11 (2011).","DOI":"10.1128\/JVI.05304-11"},{"key":"49","doi-asserted-by":"publisher","unstructured":"49\uff09\tAsper, M. et al. Inhibition of Different Lassa Virus Strains by Alpha and Gamma Interferons and Comparison with a Less Pathogenic Arenavirus. Journal of Virology 78, 3162-3169, doi:10.1128\/jvi.78.6.3162-3169.2004 (2004).","DOI":"10.1128\/JVI.78.6.3162-3169.2004"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50\uff09\tHuang, C. et al. Potent inhibition of Junin virus infection by interferon in murine cells. PLoS Negl Trop Dis 8, e2933, doi:10.1371\/journal.pntd.0002933 (2014).","DOI":"10.1371\/journal.pntd.0002933"},{"key":"51","doi-asserted-by":"publisher","unstructured":"51\uff09\tMantlo, E., Paessler, S. & Huang, C. Differential Immune Responses to Hemorrhagic Fever-Causing Arenaviruses. Vaccines (Basel) 7, doi:10.3390\/vaccines 7040138 (2019).","DOI":"10.3390\/vaccines"},{"key":"52","doi-asserted-by":"publisher","unstructured":"52\uff09\tMoreno, H., Moller, R., Fedeli, C., Gerold, G. & Kunz, S. Comparison of the Innate Immune Responses to Pathogenic and Nonpathogenic Clade B New World Arenaviruses. J Virol 93, doi:10.1128\/JVI.00148-19 (2019).","DOI":"10.1128\/JVI.00148-19"},{"key":"53","doi-asserted-by":"publisher","unstructured":"53\uff09\tCohen-Dvashi, H., Cohen, N., Israeli, H. & Diskin, R. Molecular Mechanism for LAMP1 Recognition by Lassa Virus. J Virol 89, 7584-7592, doi:10.1128\/JVI.00651-15 (2015).","DOI":"10.1128\/JVI.00651-15"},{"key":"54","doi-asserted-by":"publisher","unstructured":"54\uff09\tSommerstein, R. et al. Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection. PLoS Pathog 11, e1005276, doi:10.1371\/journal.ppat.1005276 (2015).","DOI":"10.1371\/journal.ppat.1005276"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55\uff09\tEnria D.A., O. B. J. G. Junin Virus Vaccines.  239-261 (Springer, 2002).","DOI":"10.1007\/978-3-642-56055-2_12"},{"key":"56","doi-asserted-by":"publisher","unstructured":"56\uff09\tGoni, S. E. et al. Genomic features of attenuated Junin virus vaccine strain candidate. Virus Genes 32, 37-41, doi:10.1007\/s11262-005-5843-2 (2006).","DOI":"10.1007\/s11262-005-5843-2"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57\uff09\tMaiztegui, J. I. et al. Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group. J Infect Dis 177, 277-283 (1998).","DOI":"10.1086\/514211"},{"key":"58","doi-asserted-by":"publisher","unstructured":"58\uff09\tGowen, B. B. et al. Second-Generation Live-Attenuated Candid#1 Vaccine Virus Resists Reversion and Protects against Lethal Junin Virus Infection in Guinea Pigs. J Virol 95, e0039721, doi:10.1128\/JVI.00397-21 (2021).","DOI":"10.1128\/JVI.00397-21"},{"key":"59","unstructured":"59\uff09\tPotts, P. J. M. a. J. Biosafety in Microbiological and Biomedical Laboratories. 6th edn,  (U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institutes of Health, 2020)."},{"key":"60","doi-asserted-by":"publisher","unstructured":"60\uff09\tFuruyama, W. et al. Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine. mBio, e0337921, doi:10.1128\/mbio.03379-21 (2022).","DOI":"10.1128\/mbio.03379-21"},{"key":"61","doi-asserted-by":"publisher","unstructured":"61\uff09\tSorvillo, T. E. et al. Single dose rVSVDeltaG-JUNVGP vaccine protects guinea pigs against lethal Junin virus challenge. NPJ Vaccines 6, 96, doi:10.1038\/s41541-021-00361-0 (2021).","DOI":"10.1038\/s41541-021-00361-0"},{"key":"62","doi-asserted-by":"publisher","unstructured":"62\uff09\tRegules, J. A. et al. A Recombinant Vesicular Stomatitis Virus Ebola Vaccine. N Engl J Med 376, 330-341, doi:10.1056\/NEJMoa1414216 (2017).","DOI":"10.1056\/NEJMoa1414216"},{"key":"63","doi-asserted-by":"publisher","unstructured":"63\uff09\tGolden, J. W., Maes, P., Kwilas, S. A., Ballantyne, J. & Hooper, J. W. Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever. J Virol 90, 3515-3529, doi:10.1128\/JVI.02969-15 (2016).","DOI":"10.1128\/JVI.02969-15"},{"key":"64","doi-asserted-by":"publisher","unstructured":"64\uff09\tRoman-Sosa, G. et al. Immunization with GP1 but Not Core-like Particles Displaying Isolated Receptor-Binding Epitopes Elicits Virus-Neutralizing Antibodies against Junin Virus. Vaccines (Basel) 10, doi:10.3390\/vaccines10020173 (2022).","DOI":"10.3390\/vaccines10020173"},{"key":"65","doi-asserted-by":"publisher","unstructured":"65\uff09\tClark, L. E. et al. Vaccine-elicited receptor-binding site antibodies neutralize two New World hemorrhagic fever arenaviruses. Nat Commun 9, 1884, doi:10.1038\/s41467-018-04271-z (2018).","DOI":"10.1038\/s41467-018-04271-z"},{"key":"66","doi-asserted-by":"publisher","unstructured":"66\uff09\tAzim, K. F. et al. Combination of highly antigenic nucleoproteins to inaugurate a cross-reactive next generation vaccine candidate against Arenaviridae family. Heliyon 7, e07022, doi:10.1016\/j.heliyon.2021.e07022 (2021).","DOI":"10.1016\/j.heliyon.2021.e07022"},{"key":"67","doi-asserted-by":"publisher","unstructured":"67\uff09\tAlbarino, C. G. et al. The major determinant of attenuation in mice of the Candid1 vaccine for Argentine hemorrhagic fever is located in the G2 glycoprotein transmembrane domain. J Virol 85, 10404-10408, doi: 10.1128\/JVI.00856-11 (2011).","DOI":"10.1128\/JVI.00856-11"},{"key":"68","doi-asserted-by":"publisher","unstructured":"68\uff09\tSeregin, A. V. et al. The glycoprotein precursor gene of Junin virus determines the virulence of the Romero strain and the attenuation of the Candid #1 strain in a representative animal model of Argentine hemorrhagic fever. J Virol 89, 5949-5956, doi:10.1128\/JVI.00104-15 (2015).","DOI":"10.1128\/JVI.00104-15"},{"key":"69","doi-asserted-by":"publisher","unstructured":"69\uff09\tMantlo, E. K. et al. Machupo Virus with Mutations in the Transmembrane Domain and Glycosylation Sites of the Glycoprotein Is Attenuated and Immunogenic in Animal Models of Bolivian Hemorrhagic Fever. J Virol, e0020922, doi:10.1128\/jvi.00209-22 (2022).","DOI":"10.1128\/jvi.00209-22"},{"key":"70","doi-asserted-by":"publisher","unstructured":"70\uff09\tKoma, T. et al. Glycoprotein N-linked glycans play a critical role in arenavirus pathogenicity. PLoS Pathog 17, e1009356, doi:10.1371\/journal.ppat.1009356 (2021).","DOI":"10.1371\/journal.ppat.1009356"},{"key":"71","doi-asserted-by":"publisher","unstructured":"71\uff09\tPatterson, M. et al. A substitution in the transmembrane region of the glycoprotein leads to an unstable attenuation of Machupo virus. J Virol 88, 10995-10999, doi:10.1128\/JVI.01007-14 (2014).","DOI":"10.1128\/JVI.01007-14"},{"key":"72","doi-asserted-by":"publisher","unstructured":"72\uff09\tKoma, T. et al. Machupo Virus Expressing GPC of the Candid#1 Vaccine Strain of Junin Virus Is Highly Attenuated and Immunogenic. J Virol 90, 1290-1297, doi:10.1128\/JVI.02615-15 (2016).","DOI":"10.1128\/JVI.02615-15"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73\uff09\tKoma, T. et al. The Ectodomain of Glycoprotein from the Candid#1 Vaccine Strain of Junin Virus Rendered Machupo Virus Partially Attenuated in Mice Lacking IFN-alphabeta\/gamma Receptor. PLoS Negl Trop Dis 10, e0004969, doi:10.1371\/journal.pntd.0004969 (2016).","DOI":"10.1371\/journal.pntd.0004969"},{"key":"74","doi-asserted-by":"publisher","unstructured":"74\uff09\tLeske, A. et al. Assessing cross-reactivity of Junin virus-directed neutralizing antibodies. Antiviral Res 163, 106-116, doi:10.1016\/j.antiviral.2019.01.006 (2019).","DOI":"10.1016\/j.antiviral.2019.01.006"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75\uff09\tHallam, S. J. et al. A single mutation (V64G) within the RING Domain of Z attenuates Junin virus. PLoS Negl Trop Dis 14, e0008555, doi:10.1371\/journal.pntd. 0008555 (2020).","DOI":"10.1371\/journal.pntd.0008555"},{"key":"76","doi-asserted-by":"publisher","unstructured":"76\uff09\tEnria, D. A., Briggiler, A. M. & Sanchez, Z. Treatment of Argentine hemorrhagic fever. Antiviral Res 78, 132-139, doi:10.1016\/j.antiviral.2007.10.010 (2008).","DOI":"10.1016\/j.antiviral.2007.10.010"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77\uff09\tPan, X., Wu, Y., Wang, W., Zhang, L. & Xiao, G. Novel neutralizing monoclonal antibodies against Junin virus. Antiviral Res 156, 21-28, doi:10.1016\/j.antiviral. 2018.06.002 (2018).","DOI":"10.1016\/j.antiviral.2018.06.002"},{"key":"78","doi-asserted-by":"publisher","unstructured":"78\uff09\tAmanat, F. et al. Monoclonal Antibodies with Neutralizing Activity and Fc-Effector Functions against the Machupo Virus Glycoprotein. J Virol 94, doi:10.1128\/JVI.01741-19 (2020).","DOI":"10.1128\/JVI.01741-19"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79\uff09\tZeitlin, L. et al. Monoclonal antibody therapy for Junin virus infection. Proc Natl Acad Sci U S A 113, 4458-4463, doi:10.1073\/pnas.1600996113 (2016).","DOI":"10.1073\/pnas.1600996113"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80\uff09\tZeitlin, L. et al. Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody. Proc Natl Acad Sci U S A 118, doi:10.1073\/pnas.2023332118 (2021).","DOI":"10.1073\/pnas.2023332118"},{"key":"81","doi-asserted-by":"publisher","unstructured":"81\uff09\tLinero, F. et al. Neutralization of Junin virus by single domain antibodies targeted against the nucleoprotein. Sci Rep 8, 11451, doi:10.1038\/s41598-018-29508-1 (2018).","DOI":"10.1038\/s41598-018-29508-1"},{"key":"82","doi-asserted-by":"publisher","unstructured":"82\uff09\tAmanat, F. et al. Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses. mSphere 3, doi:10.1128\/mSphere.00189-18 (2018).","DOI":"10.1128\/mSphere.00189-18"},{"key":"83","unstructured":"83\uff09\tHickerson, B. T. et al. Host receptor-targeted therapeutic approach to counter pathogenic New World mammarenavirus infections. Nat Commun 13, 558, doi:10. 1038\/s41467-021-27949-3 (2022)."},{"key":"84","doi-asserted-by":"publisher","unstructured":"84\uff09\tFerrero, S. et al. Antibody-Based Inhibition of Pathogenic New World Hemorrhagic Fever Mammarenaviruses by Steric Occlusion of the Human Transferrin Receptor 1 Apical Domain. J Virol 95, e0186820, doi:10.1128\/JVI.01868-20 (2021).","DOI":"10.1128\/JVI.01868-20"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85\uff09\tSakurai, Y. et al. Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science 347, 995-998, doi:10.1126\/ science.1258758 (2015).","DOI":"10.1126\/science.1258758"},{"key":"86","doi-asserted-by":"publisher","unstructured":"86\uff09\tRathbun, J. Y. et al. Novel Arenavirus Entry Inhibitors Discovered by Using a Minigenome Rescue System for High-Throughput Drug Screening. J Virol 89, 8428-8443, doi:10.1128\/JVI.00997-15 (2015).","DOI":"10.1128\/JVI.00997-15"},{"key":"87","doi-asserted-by":"publisher","unstructured":"87\uff09\tGowen, B. B. et al. Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin. PLoS One 3, e3725, doi:10.1371\/journal.pone.0003725 (2008).","DOI":"10.1371\/journal.pone.0003725"},{"key":"88","doi-asserted-by":"publisher","unstructured":"88\uff09\tGowen, B. B. et al. In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections. Antimicrob Agents Chemother 51, 3168-3176, doi: 10.1128\/AAC.00356-07 (2007).","DOI":"10.1128\/AAC.00356-07"},{"key":"89","doi-asserted-by":"publisher","unstructured":"89\uff09\tGowen, B. B. et al. Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models. Antiviral Res 86, 121-127, doi:10.1016\/j.antiviral.2009.10.015 (2010).","DOI":"10.1016\/j.antiviral.2009.10.015"},{"key":"90","doi-asserted-by":"publisher","unstructured":"90\uff09\tWestover, J. B. et al. Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses. Antiviral Res 126, 62-68, doi: 10.1016\/j.antiviral.2015.12.006 (2016).","DOI":"10.1016\/j.antiviral.2015.12.006"},{"key":"91","doi-asserted-by":"publisher","unstructured":"91\uff09\tLavanya, M., Cuevas, C. D., Thomas, M., Cherry, S. & Ross, S. R. siRNA screen for genes that affect Junin virus entry uncovers voltage-gated calcium channels as a therapeutic target. Sci Transl Med 5, 204ra131, doi:10.1126\/scitranslmed.3006827 (2013).","DOI":"10.1126\/scitranslmed.3006827"},{"key":"92","doi-asserted-by":"publisher","unstructured":"92\uff09\tHan, Z. et al. Calcium Regulation of Hemorrhagic Fever Virus Budding: Mechanistic Implications for Host-Oriented Therapeutic Intervention. PLoS Pathog 11, e1005220, doi:10.1371\/journal.ppat.1005220 (2015).","DOI":"10.1371\/journal.ppat.1005220"},{"key":"93","doi-asserted-by":"publisher","unstructured":"93\uff09\tBrunetti, J. E., Quintana, V. M., Scolaro, L. A. & Castilla, V. Inhibitors of the p38 cell signaling pathway as antiviral compounds against Junin virus. Arch Virol 167, 935-940, doi:10.1007\/s00705-022-05388-9 (2022).","DOI":"10.1007\/s00705-022-05388-9"},{"key":"94","doi-asserted-by":"publisher","unstructured":"94\uff09\tLu, J. et al. A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress. J Virol 88, 4736-4743, doi:10.1128\/JVI.03757-13 (2014).","DOI":"10.1128\/JVI.03757-13"},{"key":"95","doi-asserted-by":"publisher","unstructured":"95\uff09\tUrata, S. et al. Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease. J Virol 85, 795-803, doi:JVI.02019-10 [pii] 10.1128\/JVI.02019-10 (2011).","DOI":"10.1128\/JVI.02019-10"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96\uff09\tPasquato, A. et al. Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1\/site-1 protease inhibitor PF-429242. Virology 423, 14-22, doi:S0042-6822(11)00536-8 [pii] 10.1016\/j.virol. 2011.11.008 (2012).","DOI":"10.1016\/j.virol.2011.11.008"}],"container-title":["Uirusu"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/72\/1\/72_7\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T05:21:58Z","timestamp":1715577718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/72\/1\/72_7\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2222\/jsv.72.7","relation":{},"ISSN":["0042-6857","1884-3433"],"issn-type":[{"value":"0042-6857","type":"print"},{"value":"1884-3433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]}}}